Atlas Trials

Plasma Therapy of COVID-19 in Severely Ill Patients

Clinical trial NCT04359810 · COMPLETED

Trial details

NCT number
NCT04359810
Sponsor
Max O'Donnell
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
SARS-CoV-2 Infection
Start date
2020-04-21
Primary completion
2020-12-30
Enrollment
223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.